I didn't just cross a line I tripped over an edge: Experiences of serious adverse effects with selective serotonin reuptake inhibitor use

New Zealand Journal of Psychology

Volumn 37, Issue 1, 2008, Pages 38-48

  Liebert, Rachel ^a   Gavey, Nicola ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50049125094     PISSN: 0112109X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ADRAC. (2004, 15 October 2004). Use of SSRI Antidepressants in Children and Adolescents. Retrieved 6 August, 2005, from http://www.tga.gov.au/adr/ adrac ssri.pdf
2. Breggin, P. (2003). Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): a review and analysis. International Journal of Risk and Safety in Medicine, 16(1), 31 - 49.
3. Breggin, P., & Cohen, D. (1999). Your Drug May Be Your Problem. Cambridge, Massachusetts: Perseus Publishing.
4. Chesler, P. (1972). Women and Madness. New York: Avon Books.
5. DeGrandpre, R. (2002, 17th August 2002). The Lilly Suicides. Retrieved 15th December, 2005, from http://www. cultureshocktv.com/internews/2002/ augl7200261061.shtml
6. Donovan, S., Madeley, R., Clayton, A., Beeharry, M., Jones, S., Kirk, C., et al. (2000). Deliberate self harm and antidepressant drugs: investigation of possible links. The British Journal of Psychiatry, 177, 551 - 556.
7. EMEA. (2005, 25 April 2005). European Medicines Agency Finalises Review of Antidepressants in Children and Adolescents. Retrieved 6 August, 2005, from http://www.emea.eu.int/pdfs/ human/press/pr/12891805en.pdf
8. FDA. (2005). Suicidality in Adults Being Treated With Antidepressant Medications. FDA Public Health Advisory Retrieved 6 August, 2005, from http://www.fda.gov/ cder/drug/advisory/SSRI200507.htm
9. Gardner, P. (2003). Distorted packaging: Marketing depression as illness, drugs as cure. Journal of Medical Humanities, 24(1/2), 105 - 130.
10. Glenmullen, J. (2000). Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil and Other Antidepressants with Safe, Effective Alternatives. New York: Touchstone.
11. Health Canada. (2004, 3 June 2004). Health Canada Advises Canadians of Stronger Warnings for SSRIs and other Newer Antidepressants. Retrieved 6 August, 2005, from http:// www.hc-sc.gc.ca/english/protection/ warnings/2004/2004_31. htm
12. Healy, D. (2004a). Let Them Eat Prozac: The Unhealthy Relationship between the Pharmaceutical Industry and Depression. New York and London: New York University Press.
13. Healy, D. (2004b). Shaping the intimate: influences on the experience of everyday nerves. Social Studies of Science, 34(2), 219-245.
14. Healy, D. (2006). Did regulators fail over selective serotonin reuptake inhibitors? BMJ 333(7558), 92-95.
15. Healy, D., Herxheimer, A., & Menkes, D. (2006). Antidepressants and violence: Problems at the interface of medicine and law PLoS Medicine, 3(9), 1478-1487.
16. Healy, D., & Whitaker, C. (2003). Antidepressants and suicide: risk-benefit conundrums. Journal of Psychiatry and Neuroscience, 28(5), 331 - 337.
17. Khan, A., Khan, S., Leventhal, R., & Brown, W. (2001). Symptom reduction and suicide risk on patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration database. International Journal of Neuropsychopharmacology, 4(2), 113-118.
18. Kraus, J. (2006, May). Important Prescribing Information. Retrieved 6 June, 2006, from http://www.fda.gov/medwatch/ safetv/2006/paroxetineDHCPMav06. pdf
19. Lacasse, J., & Leo, J. (2005). Serotonin and depression: A disconnect between the advertisements and the scientific literature. PLoS Medicine, 2(12), 1211-1216.
20. Liebert, R. (2006). Medicate Me Into Madness: Knowledges of Adverse Effects from Selective Serotonin Reuptake Inhibitor Use. Unpublished Masters, University of Auckland, Auckland.
21. Liebert, R., & Gavey, N. (2006). "There are always two sides to these things": Managing the Dilemmas of Serious Adverse Effects from SSRI Use. Radical Psychology, 5.
22. Liebert, R., & Gavey, N. (submitted for publication). "There are always two sides to these things": Negotiating dilemmas of serious adverse effects from SSRI use
23. Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., et al. (2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. British Medical Journal, 330(389).
24. Medawar, C., Herxheimer, A., Bell, A., & Jofre, S. (2002). Paroxetine, Panorama, and user reporting of ADRs: Consumer intelligence matters in clinical practice and post-marketing drug surveillance. The International Journal of Risk and Safety in Medicine, 15, 161-169.
25. Medsafe. (2004,19 October 2004). Updated Information and Advice about the Use of Antidepressant Medicines. Dear Health Professional Retrieved 6 August, 2005, from http://www.medsafe.govt. nz/downloads/HPLtrAntidepresantMed. pdf
26. MHRA. (2003, loth December 2003). Selective serotonin reuptake inhibitors (SSRIs): Overview of regulatory status and CSM advice relating to Major Depressive Disorder (MDD) in children and adolescents including a summary of available safety and efficacy data. Retrieved 12th July, 2006, from http://www.mhra.gov.uk/home/ idcplg?IdcService=SS_GET_PAGE&u seSecondarv=true&ssDocName=CON0 19494&ssTargetNodeId=833
27. Moncrieff, J., & Kirsch, I. (2005). Efficacy of antidepressants in adults. British Medical Journal, 331(7509), 155 - 157.
28. Moynihan, R., & Cassels, A. (2005). Selling Sickness: How the World's Biggest Pharmaceutical Companies are Turning Us All into Patients. New York: Nation Books.
29. Putten, T. (1975). The many faces of akathisia. Comprehensive Psychiatry, 16(1), 43 - 47.
30. Safer, D., & Zito, J. (2007). Do antidepressants reduce suicide rates? Public Health, 121(4), 274-277
31. Simon, G. (2006). How can we know whether antidepressants increase suicide risk? American Journal of Psychiatry, 163(11), 1861-1863.
32. Teicher, M., Glod, C., & Cole, J. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207-210.
33. Tiihonen, J., Lonnqvist, J., & Wahlbeck, K. (2006). Antidepressants and the risk of suicde, attempted suicide and overall mortality in a nationwide cohort. Archives of General Psychiatry, 63(12), 1358-1367.
34. Whitaker, R. (2005). Anatomy of an epidemic: psychiatric drugs and the astonishing rise of mental illness in America. Ethical Human Psychology and Psychiatry, 7(1), 23 - 35.